- Company Overview for ACORUS THERAPEUTICS LIMITED (03976183)
- Filing history for ACORUS THERAPEUTICS LIMITED (03976183)
- People for ACORUS THERAPEUTICS LIMITED (03976183)
- Charges for ACORUS THERAPEUTICS LIMITED (03976183)
- More for ACORUS THERAPEUTICS LIMITED (03976183)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
14 Oct 2024 | TM01 | Termination of appointment of Miguel Angel Pardos Blanco as a director on 30 September 2024 | |
25 Sep 2024 | AA | Audit exemption subsidiary accounts made up to 31 December 2023 | |
25 Sep 2024 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/23 | |
25 Sep 2024 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/23 | |
25 Sep 2024 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/23 | |
29 Apr 2024 | CS01 | Confirmation statement made on 16 April 2024 with no updates | |
14 Oct 2023 | AA | Audit exemption subsidiary accounts made up to 31 December 2022 | |
14 Oct 2023 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/22 | |
14 Oct 2023 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/22 | |
14 Oct 2023 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/22 | |
21 Apr 2023 | CS01 | Confirmation statement made on 16 April 2023 with no updates | |
01 Oct 2022 | AA | Audit exemption subsidiary accounts made up to 31 December 2021 | |
01 Oct 2022 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/21 | |
01 Oct 2022 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/21 | |
01 Oct 2022 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/21 | |
08 Jun 2022 | TM01 | Termination of appointment of Christopher Paul Spooner as a director on 31 May 2022 | |
26 May 2022 | AP01 | Appointment of Mr Miguel Angel Pardos Blanco as a director on 28 April 2022 | |
26 May 2022 | TM01 | Termination of appointment of Alan Musgrave Olby as a director on 13 May 2022 | |
29 Apr 2022 | CS01 | Confirmation statement made on 16 April 2022 with no updates | |
29 Sep 2021 | AA | Audit exemption subsidiary accounts made up to 31 December 2020 | |
29 Sep 2021 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/20 | |
29 Sep 2021 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/20 | |
29 Sep 2021 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/20 | |
20 Apr 2021 | CS01 | Confirmation statement made on 16 April 2021 with no updates | |
20 Apr 2021 | PSC05 | Change of details for Is Pharma Ltd as a person with significant control on 16 April 2018 |